BiotechTube

Permethrin Cream, 5% + Elimite

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Scabies

Conditions

Scabies

Trial Timeline

Nov 1, 2016 → May 1, 2017

NCT ID
NCT02978508

About Permethrin Cream, 5% + Elimite

Permethrin Cream, 5% + Elimite is a phase 3 stage product being developed by Mayne Pharma Group for Scabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02978508. Target conditions include Scabies.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02978508Phase 3Completed

Competing Products

3 competing products in Scabies

See all competitors
ProductCompanyStageHype Score
Spinosad TopicalInotivApproved
77
Permethrin Foam 4% + Permethrin Foam 5% + Vehicle FoamViatrisPhase 2
49
PermethrinDr. Reddy's LaboratoriesPhase 3
74

Other Products from Mayne Pharma Group

Sporanox + LozanocApproved
77
Halobetasol Topical FoamApproved
77
Doxycycline Hyclate Delayed-Release 200 mgApproved
77
Slow release oral morphine (SROM) + MethadonePhase 3
69
Ivermectin 0.5% Topical Application Lotion + Ivermectin 0.5% Topical Application Lotion [SKLICE] + Placebo 0% LotionPhase 3
69